Drug Profile
Research programme: skin disorder therapies - Ampika
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Ampika
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Skin disorders; Wounds
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Skin-disorders in United Kingdom
- 28 Sep 2020 No recent reports of development identified for research development in Wounds in United Kingdom
- 11 Aug 2016 Research programme: skin disorder therapies - Ampika is available for licensing as of 11 Aug 2016. http://www.ampika.com/